1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends

The Global Market for Pain Management Drugs and Devices

  • August 2017
  • 251 pages
  • BCC Research
Report ID: 1080064


Table of Contents

• The global market for pain management will grow from nearly $36.1 billion in 2017 to $52.0 billion by 2022, with a compound annual growth rate (CAGR) of 7.6% for the period of 2017-2022.
• The pharmaceutical segment will grow from $32.3 billion in 2017 to $47.6 billion by 2022, rising at a CAGR of 8.1%.
• The device segment is expected to increase from $3.7 billion in 2017 to nearly $4.4 billion by 2022 with a CAGR of 3.3%.

Chapter 1: Introduction

Study Goals and Objectives
This BCC Research report, The Global Market for Pain Management Drugs and Devices, provides an overview of products included in this market, and detailed analyses of markets and competitive environments. The study includes information about significant products, players, issues and trends, regulatory issues, and other information affecting the pain management industry.

Reasons for Doing This Study
This study will provide the reader with the knowledge to adequately view and assess pain management and the problems that the healthcare industry faces in this space. The study also provides insights into the market potential in both the pharmaceutical and device segments. This covers a wide variety of treatments and products that many people worldwide rely on; however, there are several areas where treatment is inadequate and underserved. The report is designed to provide the reader with a background of the pain management industry, current factors influencing growth and provide decision makers with the tools to make decisions regarding expanding or exiting from the pain management industry.

Scope of Report
This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the markets for pain management. The geographical scope of this study is global. This study will address acute versus chronic pain, treatments and regulatory issues facing healthcare workers. Also provided is detailed information based on product categories, use of products, forecasts and competitive analyses.

The report identifies two general segments of pain management:
• Pharmaceuticals.
• Devices.

Within the pharmaceuticals segment several sub-segments are discussed in detail including:
• Narcotic pain management.
• Non-narcotic pain management.
• Antimigraine treatments.
• Anesthetics.
• Other drugs (including CNS therapies).

The device segment covers several product lines and specifically targets the largest product segments including:
• Electrotherapy stimulators.
• Spine stimulators.
• Other products (including electromagnetic therapies and other treatments).

Each market segment provides detailed information based on product categories, product use, forecasts and competitive analyses. Not covered in the report are drugs or devices that by treating the condition or disorder result in the relief of pain. These include treatments for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis or other similar diseases. Treatments are only included for those that indicate a relief of pain symptoms associated with these conditions. A comparison of a treatment for the disease that naturally relieves the symptoms as compared to treatments for the relief of pain associated with the disease include:

• Enbrel1: Indicated for the treatment of moderate-to-severe rheumatoid arthritis.
• Celebrex2: Indicated for the treatment of the signs and symptoms of osteoarthritis and rheumatoid arthritis and the management of acute pain.

The report is also evaluated in terms of application, discussing market trends and performance for the following areas:
• Surgical pain.
• Orthopedic/musculoskeletal pain.
• Migraine pain.
• Fibromyalgia pain.
• Cancer pain.
• Neuropathic pain.
• HIV/AIDS pain.
• Dental pain.
• General pain.
1 Pfizer Inc. product label
2 Pfizer Inc. product label

Methodology and Information Sources
The information for this BCC Research report was obtained through primary and secondary data collection methods. Primary methods included interviews with nearly 50 industry experts and participants, including industry executives, physicians, nurses, product managers and other professionals involved in the pain treatment industry. Secondary methods includes published literature in pain management, insurance and reimbursement databases, investment reports, company literature and various related journals. Market data for this report pertains to the global market and uses U.S. dollars at the manufacturers’ level. The base year of the report is 2017, with historical data provided for 2014 through 2016, and forecast data provided through 2022. Historical, base year and forecast data are provided for each market segment of the report. Growth rates are determined through a compilation of data, including past trends, future trends, demographics, incidence, mortality, products in research and development, and current product growth, etc.

Geographic Breakdown
The markets for pain management drugs and devices are divided into four broad regions:

North America
• Canada.
• United States.

Europe, Middle East, Africa (EMEA)
• Egypt.
• France.
• Germany.
• Iran.
• Iraq.
• Israel.
• Italy.
• Poland.
• Russia.
• Saudi Arabia.
• Spain.
• Turkey.
• Ukraine.
• United Kingdom.

• Australia.
• China.
• India.
• Indonesia.
• Japan.
• Malaysia.
• New Zealand.
• Philippines.
• South Korea.
• Singapore.
• Taiwan.
• Thailand.
• Vietnam.

Latin America
• Argentina.
• Brazil.
• Colombia.
• Mexico.
• Venezuela.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Ahmad helps you find the right report:


The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Global Pain Therapeutics Market to 2023 - Innovative New Products to Address Unmet Need within Chronic Pain and Migraine, and Tackle Opioid Abuse

  • $ 4995
  • Industry report
  • June 2017
  • by GBI Research

Global Pain Therapeutics Market to 2023 - Innovative New Products to Address Unmet Need within Chronic Pain and Migraine, and Tackle Opioid Abuse Summary Pain can be classified into three main categories. ...

Global Biosimilars Market

  • $ 4250
  • Industry report
  • July 2017
  • by Mordor Intelligence LLP

The global biosimilar market was estimated to be USD XX million in 2016 and is expected to reach USD XX million by 2021, witnessing a CAGR of XX% during the forecast period. Biosimilar is a biological ...

Pain Management - Medical Devices Pipeline Assessment, 2017

  • $ 4000
  • Industry report
  • September 2017
  • by GlobalData

Pain Management - Medical Devices Pipeline Assessment, 2017 Summary GlobalData’s Medical Devices sector report, “Pain Management - Medical Devices Pipeline Assessment, 2017" provides an overview of ...


Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.